CIK 0001582313
- Large accelerated filer
Xenon Pharmaceuticals Inc.
Sign in to watch- Ticker
- XENE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- EIN
- 980661854
- Phone
- +1 604-484-3300
- Business address
- 200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion CEO acquired 57,612 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 9,437 shares at an average $9.30 ($87,778)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 23 shares at $9.31 ($214)
- 4 Exercise or conversion Director acquired 31,892 shares (option exercise)
- 4 Exercise or conversion EVP, Strategy & Innovation acquired 6,172 shares (option exercise)
- 4 Exercise or conversion Director acquired 2,057 shares (option exercise)
- 4 Exercise or conversion Director acquired 20,576 shares (option exercise)
- 4 Gift Director gave 24,045 shares (gift)
- 4 Gift Director gave 5,000 shares (gift)
- 4 Exercise or conversion Director acquired 2,057 shares (option exercise)
- 4 Exercise or conversion VP, Biology acquired 4,115 shares (option exercise)
Page 10 of 19 · 370 filings